Palvella Therapeutics, Inc. Assets Held-for-sale, Not Part of Disposal Group, Current
Palvella Therapeutics, Inc. (PVLA) had Assets Held-for-sale, Not Part of Disposal Group, Current of $0 as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent · last filed 2024-11-13
- 2024-09-30: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
- 2024-06-30: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
- 2024-03-31: Assets Held-for-sale, Not Part of Disposal Group, Current $196.00K.
- 2023-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $2.19M.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $196.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.19M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $2.10M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |